PDE4B and idiopathic pulmonary fibrosis: In addition to CC-11050, the beneficial effect of another phosphodiesterase 4B inhibitor (BI 1015550) has been tested in patients with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis (72–75).